Thermo Fisher Scientific (TMO) FCF Margin (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported FCF Margin for 18 consecutive years, with 13.97% the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, FCF Margin rose 379.0% year-over-year to 13.97%; the trailing twelve-month figure through Jun 2026 stood at 15.79% (up 151.0% YoY), and the FY2025 full-year result was 14.12%, down 282.0% from the prior year.
• FCF Margin improved to 13.97% in Q2 2026 per TMO's latest filing, from 7.41% in the prior quarter.
• Across five years, FCF Margin topped out at 30.48% in Q4 2023 and bottomed at 2.53% in Q2 2023.
• Historically, FCF Margin has averaged 14.93% across 5 years, with a median of 13.59% in 2022.
• The sharpest annual moves came in 2022 and 2023: FCF Margin surged 1046 bps in 2022, then sank 1069 bps in 2023.
• Over 5 years, FCF Margin stood at 25.65% in 2022, then grew by 19 bps to 30.48% in 2023, then slipped by 19 bps to 24.66% in 2024, then slipped by 1 bps to 24.49% in 2025, then tumbled by 43 bps to 13.97% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 13.97%, 7.41%, and 24.49% for Q2 2026, Q1 2026, and Q4 2025 respectively.